Adhera Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
FRENCH J MICHAEL director, officer: President an..
MDRNA, Inc. Common Stock 100 $0.76 $76
Sale
COSTANTINO HENRY R officer: CSO - Delivery
MDRNA, Inc. Common Stock 231 $1.01 $233
Sale
COSTANTINO HENRY R officer: CSO - Delivery
MDRNA, Inc. Common Stock 240 $1.17 $281
Sale
COSTANTINO HENRY R officer: CSO - Delivery
MDRNA, Inc. Common Stock 81 $1.19 $96
Sale
DUFFY TIMOTHY M officer: Chief Business Officer
MDRNA, Inc. Common Stock 200 $1.19 $238
Purchase
THAW BRUCE R/FA director
Nastech Pharmaceutical Company Common Stock 4,112 $1.33 $5,469
Purchase
THAW BRUCE R/FA director
Nastech Pharmaceutical Company Common Stock 2,500 $1.23 $3,075
Purchase
THAW BRUCE R/FA director
Nastech Pharmaceutical Company Common Stock 4,086 $1.13 $4,617
Purchase
THAW BRUCE R/FA director
Nastech Pharmaceutical Company Common Stock 800 $1.14 $912
Purchase
THAW BRUCE R/FA director
Nastech Pharmaceutical Company Common Stock 36,602 $1.15 $42,092
Purchase
THAW BRUCE R/FA director
Nastech Pharmaceutical Company Common Stock 1,900 $1.24 $2,356
Purchase
STANEWICK GERALD T director
Nastech Pharmaceutical Company Inc Common Stock 10,000 $1.14 $11,400
Purchase
STANEWICK GERALD T director
Nastech Pharmaceutical Company Inc Common Stock 4,100 $2.4 $9,840
Purchase
STANEWICK GERALD T director
Nastech Pharmaceutical Company Inc Common Stock 900 $2.39 $2,151
Purchase
YORK BRUCE R officer: CFO and Secretary
Nastech Pharmaceutical Company Inc Common Stock 2,000 $4.04 $8,080
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 100 $14.41 $1,441
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 1,000 $14.85 $14,850
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 1,000 $14.85 $14,850
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 167 $14.73 $2,460
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 200 $14.71 $2,942
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 133 $14.7 $1,955
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 400 $14.42 $5,768
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 1,000 $16 $16,000
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 500 $16.05 $8,025
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 100 $14 $1,400
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 100 $14 $1,400
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 100 $14 $1,400
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 200 $13.8 $2,760
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 100 $14 $1,400
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 100 $14 $1,400
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 200 $13.8 $2,760
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 300 $13.48 $4,044
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 100 $14 $1,400
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 200 $13.8 $2,760
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 200 $13.8 $2,760
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 200 $13.8 $2,760
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 200 $13.8 $2,760
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 200 $13.8 $2,760
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 100 $14 $1,400
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 200 $13.8 $2,760
Sale
WENIG DEVIN director
Nastech Pharmaceutical Company Inc Common Stock 400 $13.75 $5,500
Sale
QUAY STEVEN C director
Nastech Pharmaceutical Company Inc Common Stock 1,000 $13.53 $13,530
Sale
QUAY STEVEN C director
Nastech Pharmaceutical Company Inc Common Stock 2,000 $13.52 $27,040
Sale
QUAY STEVEN C director
Nastech Pharmaceutical Company Inc Common Stock 2,000 $13.52 $27,040
Sale
QUAY STEVEN C director
Nastech Pharmaceutical Company Inc Common Stock 200 $13.42 $2,684
Sale
STANEWICK GERALD T director
Nastech Pharmaceutical Company Inc Common Stock 4,200 $14.21 $59,695
Option
JOHNSON PAUL H officer: Sr VP of R&D, CSO
Nastech Pharmaceutical Company Inc Common Stock 54,649 $9.36 $511,515
Sale
JOHNSON PAUL H officer: Sr VP of R&D, CSO
Nastech Pharmaceutical Company Inc Common Stock 2,200 $14.3 $31,460
Option
JOHNSON PAUL H officer: Sr VP of R&D, CSO
Nastech Pharmaceutical Company Inc Common Stock 2,667 $10.39 $27,710
Sale
JOHNSON PAUL H officer: Sr VP of R&D, CSO
Nastech Pharmaceutical Company Inc Common Stock 45,000 $14.3 $643,500

Showing 100 to 150 of 301 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.